Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 3,277.00
+30.00 (0.92%)
Jun 6, 2025, 5:00 PM SAST
Dis-Chem Pharmacies Revenue
In the fiscal year ending February 28, 2025, Dis-Chem Pharmacies had annual revenue of 39.17B ZAR with 7.96% growth. Dis-Chem Pharmacies had revenue of 19.61B in the half year ending February 28, 2025, with 20.04% growth.
Revenue
39.17B
Revenue Growth
+7.96%
P/S Ratio
0.72
Revenue / Employee
1.96M
Employees
20,000
Market Cap
28.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 39.17B | 2.89B | 7.96% |
| Feb 29, 2024 | 36.28B | 3.62B | 11.08% |
| Feb 28, 2023 | 32.66B | 2.26B | 7.42% |
| Feb 28, 2022 | 30.41B | 4.13B | 15.71% |
| Feb 28, 2021 | 26.28B | 2.29B | 9.56% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clicks Group | 46.80B |
| Aspen Pharmacare Holdings | 45.53B |
| Life Healthcare Group Holdings | 26.73B |
| Netcare | 25.85B |
| Adcock Ingram Holdings | 9.62B |
| AfroCentric Investment Corporation | 8.81B |
| Ascendis Health | 734.49M |
| RH Bophelo | 111.89M |
Dis-Chem Pharmacies News
- 7 months ago - Dis-Chem Pharmacies Ltd (JSE:DCP) Half Year 2025 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 7 months ago - Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript - GuruFocus
- 8 months ago - Dis-Chem versus Clicks - Daily Investor